431 related articles for article (PubMed ID: 32381639)
1. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
[TBL] [Abstract][Full Text] [Related]
2. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
[TBL] [Abstract][Full Text] [Related]
3. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
4. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
[TBL] [Abstract][Full Text] [Related]
5. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline.
Barber TR; Griffanti L; Bradley KM; McGowan DR; Lo C; Mackay CE; Hu MT; Klein JC
Ann Clin Transl Neurol; 2020 Jan; 7(1):26-35. PubMed ID: 31820587
[TBL] [Abstract][Full Text] [Related]
6. Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT.
Takahashi H; Kashiwagi N; Arisawa A; Matsuo C; Kato H; Adachi H; Kajiyama Y; Mochizuki H; Tomiyama N
Br J Radiol; 2022 Feb; 95(1130):20210837. PubMed ID: 34808066
[TBL] [Abstract][Full Text] [Related]
7. The impact of probable rapid eye movement sleep behavior disorder on Parkinson's disease: A dual-tracer PET imaging study.
Xu Q; Jiang C; Ge J; Lu J; Li L; Yu H; Wu J; Wang J; Wu P; Zuo C
Parkinsonism Relat Disord; 2022 Feb; 95():47-53. PubMed ID: 35030449
[TBL] [Abstract][Full Text] [Related]
8. Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects.
Garrido A; Iranzo A; Stefani A; Serradell M; Muñoz-Lopetegi A; Marrero P; Högl B; Gaig C; Santamaria J; Tolosa E; Poewe W;
Mov Disord; 2020 Jun; 35(6):1072-1076. PubMed ID: 32141653
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
10. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
Eisensehr I; Linke R; Tatsch K; Kharraz B; Gildehaus JF; Wetter CT; Trenkwalder C; Schwarz J; Noachtar S
Sleep; 2003 Aug; 26(5):507-12. PubMed ID: 12938802
[TBL] [Abstract][Full Text] [Related]
11. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
[TBL] [Abstract][Full Text] [Related]
12. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
13. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
15. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
[TBL] [Abstract][Full Text] [Related]
16. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
17. REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.
Kim YE; Kim YJ; Hwang HS; Ma HI
Parkinsonism Relat Disord; 2020 Nov; 80():120-126. PubMed ID: 32987358
[TBL] [Abstract][Full Text] [Related]
18. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease.
Chung SJ; Lee S; Yoo HS; Lee YH; Lee HS; Choi Y; Lee PH; Yun M; Sohn YH
J Parkinsons Dis; 2020; 10(4):1541-1549. PubMed ID: 32925098
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
Knudsen K; Fedorova TD; Horsager J; Andersen KB; Skjærbæk C; Berg D; Schaeffer E; Brooks DJ; Pavese N; Van Den Berge N; Borghammer P
J Parkinsons Dis; 2021; 11(4):1677-1687. PubMed ID: 34334424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
